We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Petition Asks FDA to Tie Biosimilar Labeling to the Reference Product
Petition Asks FDA to Tie Biosimilar Labeling to the Reference Product
Biosimilar labeling should piggyback on reference product labeling to bolster consumer confidence in this new class of medications, according to an FDA petition.